Related Experiment Video

Updated: Oct 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Community-acquired pneumonia in ambulatory patients: relative importance of atypical pathogens

D Honeybourne1

  • 1Department of Respiratory Medicine, Birmingham Heartlands Hospital, Birmingham B9 5SS, UK. honeybd@heartsol.wmids.nhs.uk

International Journal of Antimicrobial Agents
|September 28, 2001
PubMed

Insights

Diagnosing atypical pathogens in community-acquired pneumonia is challenging. Macrolide antibiotics are recommended for suspected atypical infections due to their broad-spectrum activity.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Atypical pathogens pose diagnostic challenges in community-acquired pneumonia (CAP).
  • Current diagnostic methods like culture and serology have limitations in speed and accuracy.
  • The significance of atypical organisms in CAP is increasingly recognized, with variations across regions and patient groups.

Purpose of the Study:

  • To highlight the diagnostic difficulties associated with atypical pathogens in CAP.
  • To discuss the evolving understanding of atypical pathogen prevalence and influencing factors.
  • To recommend appropriate antibiotic choices for suspected atypical CAP.

Main Methods:

  • Literature review on atypical pathogens in CAP.
  • Analysis of diagnostic challenges and limitations.
  • Evaluation of antibiotic efficacy against atypical and common respiratory pathogens.

Main Results:

  • Atypical pathogen diagnosis is complex, with culture and serology being time-consuming and potentially inaccurate.
  • Aetiology of CAP varies geographically, by patient population, and seasonally.
  • Macrolides demonstrate activity against atypical pathogens and common respiratory bacteria.

Conclusions:

  • Macrolide antibiotics are a suitable empirical treatment choice for CAP when atypical pathogens are suspected.
  • Effective management of CAP requires consideration of pathogen variability and diagnostic limitations.
  • Further research into rapid and accurate diagnostics for atypical pathogens is warranted.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...